157 related articles for article (PubMed ID: 12974081)
41. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
[TBL] [Abstract][Full Text] [Related]
42. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
Wernert N; Raes MB; Lassalle P; Dehouck MP; Gosselin B; Vandenbunder B; Stehelin D
Am J Pathol; 1992 Jan; 140(1):119-27. PubMed ID: 1370594
[TBL] [Abstract][Full Text] [Related]
43. [Does the c-ets 1 oncogene participate in the regulation of tumor angiogenesis?].
Vandenbunder B; Wernert N; Stehelin D
Arch Inst Pasteur Tunis; 1994; 71(3-4):493-509. PubMed ID: 8801851
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.
Naito S; Shimizu K; Nakashima M; Nakayama T; Ito T; Ito M; Yamashita S; Sekine I
Pathol Res Pract; 2000; 196(2):103-9. PubMed ID: 10707367
[TBL] [Abstract][Full Text] [Related]
45. [Cloning and monoclonal antibody preparation of VEGF receptor KDR extracellular V-VII domain and KDR expression in carcinomas of different origins].
Song S; Zeng L; Wu J
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):96-8. PubMed ID: 11776867
[TBL] [Abstract][Full Text] [Related]
46. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
47. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.
Alipov G; Nakayama T; Ito M; Kawai K; Naito S; Nakashima M; Niino D; Sekine I
Histopathology; 2005 Feb; 46(2):202-8. PubMed ID: 15693893
[TBL] [Abstract][Full Text] [Related]
49. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
50. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
51. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
52. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
[TBL] [Abstract][Full Text] [Related]
53. [Effects of 5F from Pteri semipinnata on the expression of ETS-1 mRNA and VEGF protein of highly metastatic ovarian carcinoma HO-8910PM cells].
He T; Mo L; Liang N
Zhong Yao Cai; 2005 Apr; 28(4):307-9. PubMed ID: 16104507
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival.
Goncharuk IV; Vorobjova LI; Lukyanova NY; Chekhun VF
Exp Oncol; 2009 Sep; 31(3):179-81. PubMed ID: 19783962
[TBL] [Abstract][Full Text] [Related]
55. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
56. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
57. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.
Emoto M; Charnock-Jones DS; Licence DR; Ishiguro M; Kawai M; Yanaihara A; Saito T; Hachisuga T; Iwasaki H; Kawarabayashi T; Smith SK
Gynecol Oncol; 2004 Dec; 95(3):474-82. PubMed ID: 15581949
[TBL] [Abstract][Full Text] [Related]
58. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
60. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
